Lyell Immunopharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $506k | 349k | 1.45 |
| 2024-03-31 | $949k | 426k | 2.23 |
| 2023-12-31 | $1.2M | 628k | 1.94 |
| 2023-09-30 | $790k | 538k | 1.47 |
| 2023-06-30 | $2.1M | 656k | 3.18 |
| 2023-03-31 | $1.3M | 556k | 2.36 |
| 2022-12-31 | $4.2M | 1.2M | 3.47 |
| 2022-06-30 | $1.3M | 201k | 6.52 |
| 2022-03-31 | $942k | 186k | 5.05 |
| 2021-12-31 | $806k | 104k | 7.74 |